Hepatitis B re-activation with rituximab therapy: treat the patient not the disease
| dc.creator | Zachou, K. | en |
| dc.creator | Dalekos, G. N. | en |
| dc.date.accessioned | 2015-11-23T10:54:35Z | |
| dc.date.available | 2015-11-23T10:54:35Z | |
| dc.date.issued | 2011 | |
| dc.identifier | 10.1111/j.1478-3231.2011.02452.x | |
| dc.identifier.issn | 1478-3223 | |
| dc.identifier.uri | http://hdl.handle.net/11615/34774 | |
| dc.source | Liver International | en |
| dc.source.uri | <Go to ISI>://WOS:000286836900001 | |
| dc.subject | HBSAG-NEGATIVE PATIENTS | en |
| dc.subject | CYTOTOXIC CHEMOTHERAPY | en |
| dc.subject | VIRUS INFECTION | en |
| dc.subject | LAMIVUDINE | en |
| dc.subject | MANAGEMENT | en |
| dc.subject | STATEMENT | en |
| dc.subject | RISK | en |
| dc.subject | Gastroenterology & Hepatology | en |
| dc.title | Hepatitis B re-activation with rituximab therapy: treat the patient not the disease | en |
| dc.type | journalArticle | en |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||